Cargando…

A Comparative Analysis of Body Mass Index with Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Pre- and Postmenopausal Breast Cancer Patients

BACKGROUND: Breast cancer is now the most common cancer among Indian women. Recent studies have suggested a possible link between risk factors like high BMI and molecular subtypes of breast cancer. Studies from Western and Asian population have shown varying relationship between post- menopausal obe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauhan, Richa, Trivedi, Vinita, Rani, Rita, Singh, Usha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978051/
https://www.ncbi.nlm.nih.gov/pubmed/33767561
http://dx.doi.org/10.4103/jmh.JMH_97_20
_version_ 1783667147746050048
author Chauhan, Richa
Trivedi, Vinita
Rani, Rita
Singh, Usha
author_facet Chauhan, Richa
Trivedi, Vinita
Rani, Rita
Singh, Usha
author_sort Chauhan, Richa
collection PubMed
description BACKGROUND: Breast cancer is now the most common cancer among Indian women. Recent studies have suggested a possible link between risk factors like high BMI and molecular subtypes of breast cancer. Studies from Western and Asian population have shown varying relationship between post- menopausal obesity and expression of ER, PR, Her2-neu receptors in breast cancer patients. AIM: This study was done with an aim to explore if overweight or obesity as defined by BMI and status of ER, PR and Her2-neu receptors differ in Indian pre-menopausal and post-menopausal breast cancer patients. METHODS AND MATERIAL: This is a retrospective analysis of 446 breast cancer patients treated at Mahavir Cancer Sansthan, Patna from July to December 2019. Their case records were evaluated and data regarding age, menopausal status, height, weight and ER, PR & HER2-neu receptor status were extracted for analyses. STATISTICAL ANALYSIS: Chi-square test was used to compare categorical variables between the pre-menopausal and post-menopausal group. RESULTS: The prevalence of obesity in the post-menopausal group was 2.3% more than the pre-menopausal group (P-value = 0.24). As compared to the pre-menopausal group, there was an increase in the ER/PR positivity in the postmenopausal group by 3.41% (P-value = 0.47) and in the Her2-neu positivity by 6.38% (P-value = 0.15). As compared to the pre-menopausal group, there was further increase in the ER/PR positivity in the post-menopausal group by 6.85% (P-value = 0.40) in sub-group of patients with BMI ≥ 25kg/m(2). CONCLUSIONS: Our study showed slightly increased incidence of obesity in post-menopausal breast cancer patients. Overweight post-menopausal patients also had a higher percentage of ER/PR receptor positivity and lower percentage of Triple negative breast cancer. The percentage of Her2-neu receptor positivity was more in post-menopausal patients. A high BMI was found to be associated with a lower Her2neu positivity.
format Online
Article
Text
id pubmed-7978051
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-79780512021-03-24 A Comparative Analysis of Body Mass Index with Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Pre- and Postmenopausal Breast Cancer Patients Chauhan, Richa Trivedi, Vinita Rani, Rita Singh, Usha J Midlife Health Original Article BACKGROUND: Breast cancer is now the most common cancer among Indian women. Recent studies have suggested a possible link between risk factors like high BMI and molecular subtypes of breast cancer. Studies from Western and Asian population have shown varying relationship between post- menopausal obesity and expression of ER, PR, Her2-neu receptors in breast cancer patients. AIM: This study was done with an aim to explore if overweight or obesity as defined by BMI and status of ER, PR and Her2-neu receptors differ in Indian pre-menopausal and post-menopausal breast cancer patients. METHODS AND MATERIAL: This is a retrospective analysis of 446 breast cancer patients treated at Mahavir Cancer Sansthan, Patna from July to December 2019. Their case records were evaluated and data regarding age, menopausal status, height, weight and ER, PR & HER2-neu receptor status were extracted for analyses. STATISTICAL ANALYSIS: Chi-square test was used to compare categorical variables between the pre-menopausal and post-menopausal group. RESULTS: The prevalence of obesity in the post-menopausal group was 2.3% more than the pre-menopausal group (P-value = 0.24). As compared to the pre-menopausal group, there was an increase in the ER/PR positivity in the postmenopausal group by 3.41% (P-value = 0.47) and in the Her2-neu positivity by 6.38% (P-value = 0.15). As compared to the pre-menopausal group, there was further increase in the ER/PR positivity in the post-menopausal group by 6.85% (P-value = 0.40) in sub-group of patients with BMI ≥ 25kg/m(2). CONCLUSIONS: Our study showed slightly increased incidence of obesity in post-menopausal breast cancer patients. Overweight post-menopausal patients also had a higher percentage of ER/PR receptor positivity and lower percentage of Triple negative breast cancer. The percentage of Her2-neu receptor positivity was more in post-menopausal patients. A high BMI was found to be associated with a lower Her2neu positivity. Wolters Kluwer - Medknow 2020 2021-01-21 /pmc/articles/PMC7978051/ /pubmed/33767561 http://dx.doi.org/10.4103/jmh.JMH_97_20 Text en Copyright: © 2021 Journal of Mid-life Health http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Chauhan, Richa
Trivedi, Vinita
Rani, Rita
Singh, Usha
A Comparative Analysis of Body Mass Index with Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Pre- and Postmenopausal Breast Cancer Patients
title A Comparative Analysis of Body Mass Index with Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Pre- and Postmenopausal Breast Cancer Patients
title_full A Comparative Analysis of Body Mass Index with Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Pre- and Postmenopausal Breast Cancer Patients
title_fullStr A Comparative Analysis of Body Mass Index with Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Pre- and Postmenopausal Breast Cancer Patients
title_full_unstemmed A Comparative Analysis of Body Mass Index with Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Pre- and Postmenopausal Breast Cancer Patients
title_short A Comparative Analysis of Body Mass Index with Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Pre- and Postmenopausal Breast Cancer Patients
title_sort comparative analysis of body mass index with estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in pre- and postmenopausal breast cancer patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978051/
https://www.ncbi.nlm.nih.gov/pubmed/33767561
http://dx.doi.org/10.4103/jmh.JMH_97_20
work_keys_str_mv AT chauhanricha acomparativeanalysisofbodymassindexwithestrogenreceptorprogesteronereceptorandhumanepidermalgrowthfactorreceptor2statusinpreandpostmenopausalbreastcancerpatients
AT trivedivinita acomparativeanalysisofbodymassindexwithestrogenreceptorprogesteronereceptorandhumanepidermalgrowthfactorreceptor2statusinpreandpostmenopausalbreastcancerpatients
AT ranirita acomparativeanalysisofbodymassindexwithestrogenreceptorprogesteronereceptorandhumanepidermalgrowthfactorreceptor2statusinpreandpostmenopausalbreastcancerpatients
AT singhusha acomparativeanalysisofbodymassindexwithestrogenreceptorprogesteronereceptorandhumanepidermalgrowthfactorreceptor2statusinpreandpostmenopausalbreastcancerpatients
AT chauhanricha comparativeanalysisofbodymassindexwithestrogenreceptorprogesteronereceptorandhumanepidermalgrowthfactorreceptor2statusinpreandpostmenopausalbreastcancerpatients
AT trivedivinita comparativeanalysisofbodymassindexwithestrogenreceptorprogesteronereceptorandhumanepidermalgrowthfactorreceptor2statusinpreandpostmenopausalbreastcancerpatients
AT ranirita comparativeanalysisofbodymassindexwithestrogenreceptorprogesteronereceptorandhumanepidermalgrowthfactorreceptor2statusinpreandpostmenopausalbreastcancerpatients
AT singhusha comparativeanalysisofbodymassindexwithestrogenreceptorprogesteronereceptorandhumanepidermalgrowthfactorreceptor2statusinpreandpostmenopausalbreastcancerpatients